Targeting Complement in Kidney Transplantation: Therapeutic Approaches Based on Preclinical and Experimental Evidence Nakazawa D.
Transplantation Reviews, in press.
IF 3.6
{ 43件 }
Targeting Complement in Kidney Transplantation: Therapeutic Approaches Based on Preclinical and Experimental Evidence Nakazawa D.
Transplantation Reviews, in press.
IF 3.6
Effects of Canagliflozin on brain natriuretic peptide level in patients with type 2 diabetes on peritoneal dialysis in Japan:
protocol for a multicenter, prospective, randomized controlled trial (CARD-PD trial) Naoko M, Daigo N, Saori N, Kyu Y. C., Tomochika M, Nobuharu K, Rie Y, Junya Y, Mamiko S, Minoru M, Satoko I, Kento I, Yosuke I, Akiko K, Takashi K, Junpei Y, Takahiro N, Yoichi I, Tatsuya A.
BMJ open
IF: 2.4
Takashi Kudo, Daigo Nakazawa, Saori Nishio, Fumihiko Hattanda, Yusho Ueda, Junpei Yoshikawa, Satoka Shiratori-Aso, Sari Iwasaki, Takahiro Tsuji, Yasuni Nakanuma, Goki Suda, Koji Ogawa, Naoya Sakamoto, Tatsuya Atsumi Tubulointerstitial nephritis with IgM-positive plasma cells complicated by liver failure CEN Case Reports (in press) IF 1.0
Zhao D, Han C, Mammadova-Bach E, Watanabe-Kusunoki K, Bandeira Honda TS, Li Y, Li C, Li Q, Long H, Lyubenov L, Shi C, Boor P, Droste P, Parikh S, Shapiro J, Chiara L, Carangelo G, Romagnani P, Klussmann S, Vater A, Anders HJ.
Inhibition of complement factor C5a or C5aR for cholesterol crystal embolism-related microvascular thrombosis and its consequences.
Kidney International, in press
IF: 14.8
Takahashi-Kobayashi M, Sada KE, Kawashima S, Miyawaki Y, Nakazawa D, Furuichi K, Okada H, Narita I, Usui J.
Survey of Japanese nephrologists' use of clinical practice guidelines for rapidly progressive glomerulonephritis.
Clin Exp Nephrol. 2024 Apr;28(4):316-324.
IF 2.2
Yuka Nishibata, Suishin Arai, Mai Taniguchi, Issei Nakade, Hodaka Ogawa, Shota Kitano, Yumeka Hosoi, Ayano Shindo, Ryo Nishiyama, Sakiko Masuda, Daigo Nakazawa, Utano Tomaru, Takafumi Shimizu, William Sinko, Tadashi Nagakura, Yoh Terada, and Akihiro Ishizu.
Cathepsin C inhibition reduces neutrophil serine protease activity and improves activated neutrophil-mediated disorders.
Nature Communications , in press
IF 14.7
医学生・研修医・専攻医の日本内科学会ことはじめ 2024東京 指導教官賞 川村 拓朗先生
医学生・研修医・専攻医の日本内科学会ことはじめ 2024東京 優秀演題賞 磯崎 大希先生
Kanako Watanabe-Kusunoki, Chenyu Li, Tâmisa Seeko Bandeira Honda, Danyang Zhao, Yoshihiro Kusunoki, John Ku, Hao Long, Martin Klaus, Chao Han, Attila Braun, Elmina Mammadova-Bach, Andreas Linkermann, Kristof Van Avondt, Mathis Richter, Oliver Soehnlein, Monika I.
Linder, Christoph Klein, Stefanie Steiger, Hans-Joachim Anders.
Gasdermin D drives focal Crystalline Thrombotic Microangiopathy by accelerating Immunothrombosis and Necroinflammation.
Blood, in press
IF: 20.3
Ueda Y, Nakazawa D, Nishio S, Shiratori-Aso S, Kudo T, Miyoshi-Harashima A, Watanabe-Kusunoki K, Hattanda F, Iwasaki S, Tsuji T, Tomaru U, Aratani Y, Yamamoto M, Ishizu A, Atsumi T.
Nrf2 activation regulates NETosis, endothelial injury, and renal disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis.
Kidney International, in press.
IF：19.6